Analysis shows udenafil significantly improves exercise capacity in Fontan patients with reduced baseline function

A newly published, post-hoc analysis of the landmark FUEL (Fontan Udenafil Exercise Longitudinal) Trial demonstrates that udenafil, a PDE5 inhibitor, significantly improves peak oxygen consumption (peak VO₂) in adolescents with single-ventricle congenital heart disease (SV-CHD) who have undergone the Fontan procedure and have reduced exercise capacity.
Read More

Study reveals gap in stroke care guidelines for culturally diverse patients

Stroke continues to place a heavy burden on Australians, especially those from culturally and linguistically diverse (CALD) backgrounds, with a stroke occurring every 11 minutes. Yet, new research led by University of Wollongong (UOW) Ph.D. candidate Shegaw Zeleke has found a striking paradox: despite the disproportionate impact of stroke on CALD communities, stroke care guidelines worldwide lack cultural recommendations.
Read More
Top